ARTICLES BY THIS AUTHOR
- 10/30/2008
Canadian statement on PPIs and hip fracture
Recent media attention has focused on the possibility that long-term proton pump inhibitor (PPI) therapy may lead to an increased risk of hip fracture. - 10/30/2008
New Brunswick pharmacists win prescribing authority
Amendments to the Pharmacy Act that expand the role of pharmacists come into effect today. - 10/29/2008
Venlafaxine XR more dangerous than SSRIs in overdose
Overdose with venlafaxine may be associated with a higher risk of fatal outcome compared to overdose with selective serotonin reuptake inhibitor antidepressants, but lower than that seen with tricyclic antidepressants. - 10/28/2008
Health Canada advisory concerning two vitamin C supplements
Health Canada is warning consumers not to use two vitamin C products: New Roots Herbal Vitamin C8 and Vitazan Professional Vitamin C Advanced Ascorbate because they contain vitamin A instead of vitamin C. - 10/27/2008
IPO speaking out
Independent pharmacists, struggling to survive since Ontario introduced a series of major changes to the drug system, want patients to go to bat for them with the government. - 10/22/2008
Fosavance 70/5600: new tablet with more vitamin D
Merck Frosst is introducing a new strength of Fosavance (alendronate sodium/cholecalciferol) that contains a higher amount of cholecalciferol (vitamin D3). - 10/22/2008
CMA to launch fact-finding mission on European health-care reform
Dr. Robert Ouellet, president of the CMA, today announced the CMA's intention to begin an international fact-finding mission examining ideas for health care reform and renewal in several European countries. - 10/21/2008
Voltaren Emulgel: nonprescription topical NSAID
Novartis Consumer Healthcare is introducing the first nonprescription topical nonsteroidal anti-inflammatory drug to be marketed in Canada.